Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A high-density screen for linkage in multiple sclerosis.
Overcoming barriers in progressive multiple sclerosis research.
Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice.
Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome.
Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection.
Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis.
Activation of axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial.
Circulating monocytes are reduced by sphingosine-1-phosphate receptor modulators independently of S1P3.
Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis.
A complex role of herpes viruses in the disease process of multiple sclerosis.
White matter astrocytes in health and disease.
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study.
Apitope Announces Positive Results from Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
[Intractable vomiting as first manifestation of neuromyelitis Optica.]
Drak2 Does Not Regulate TGF-β Signaling in T Cells.
Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response.
Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.
Predictive value of early brain atrophy on response in patients treated with interferon β.
Rescue Therapy Using Rituximab for Multiple Sclerosis.
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice.
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Considering the influence of stimulation parameters on the effect of conventional and high-definition transcranial direct current stimulation.
The history of the oxazaphosphorine cytostatics.

Pages